Cite
MLA Citation
Megumi Oshima et al.. “Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.” Lancet, vol. 8, no. 11, 2020, pp. 903–914. http://access.bl.uk/ark:/81055/vdc_100113057807.0x000006